These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15855113)

  • 1. MRI findings of focal eosinophilic liver diseases.
    Kim YK; Kim CS; Moon WS; Cho BH; Lee SY; Lee JM
    AJR Am J Roentgenol; 2005 May; 184(5):1541-8. PubMed ID: 15855113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR findings of focal eosinophilic liver disease using gadoxetic acid.
    Lee J; Park CM; Kim KA; Lee CH; Choi JW
    Magn Reson Imaging; 2010 Nov; 28(9):1327-34. PubMed ID: 20800984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of liver lesions with gadolinium-enhanced VIBE sequence in comparison with SPIO-enhanced MRI].
    Heim P; Steiner P; Schoder V; Dieckmann C; Kuhlencordt R; Adam G
    Rofo; 2003 Oct; 175(10):1376-83. PubMed ID: 14556107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal nodular hyperplasia of the liver: serial MRI with Gd-DOTA, superparamagnetic iron oxide, and Gd-EOB-DTPA.
    Kacl GM; Hagspiel KD; Marincek B
    Abdom Imaging; 1997; 22(3):264-7. PubMed ID: 9107647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal nodular hyperplasia: lesion characteristics on state-of-the-art MRI including dynamic gadolinium-enhanced and superparamagnetic iron-oxide-uptake sequences in a prospective study.
    Terkivatan T; van den Bos IC; Hussain SM; Wielopolski PA; de Man RA; IJzermans JN
    J Magn Reson Imaging; 2006 Oct; 24(4):864-72. PubMed ID: 16947339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal eosinophilic infiltration of the liver: gadoxetic acid-enhanced magnetic resonance imaging and diffusion-weighted imaging.
    Ahn SJ; Choi JY; Kim KA; Kim MJ; Baek SE; Kim JH; Song HT
    J Comput Assist Tomogr; 2011; 35(1):81-5. PubMed ID: 21160434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-contrast MRI (DC-MRI) in the study of the cirrhotic liver: utility of administering Gd-DTPA as a complement to examinations in which SPIO liver uptake and distribution alterations (SPIO-LUDA) are present and in the identification and characterisation of focal lesions.
    Macarini L; Marini S; Milillo P; Vinci R; Ettorre GC
    Radiol Med; 2006 Dec; 111(8):1087-102. PubMed ID: 17171525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative assessment of iron-oxide-enhanced magnetic resonance imaging of the liver: Vessel isointensity is a potential characteristic of liver hemangiomas on late T1-weighted images.
    Schmitz SA; Nikolova A; O'Regan D; Albrecht T; Hohmann J; Wolf KJ
    Acta Radiol; 2006 Sep; 47(7):634-42. PubMed ID: 16950695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superparamagnetic iron oxide (SPIO)-enhanced liver MRI with ferucarbotran: efficacy for characterization of focal liver lesions.
    Namkung S; Zech CJ; Helmberger T; Reiser MF; Schoenberg SO
    J Magn Reson Imaging; 2007 Apr; 25(4):755-65. PubMed ID: 17335040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Magnetic resonance imaging of the liver: what kind of contrast agents?].
    De Gaspari A; De Cobelli F; Del Maschio A
    Radiol Med; 2001 Sep; 102(3):109-21. PubMed ID: 11677451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesions: an ROC analysis].
    Stroszczynski C; Gaffke G; Gretschel S; Rambow A; Jost D; Schlecht I; Schneider U; Schicke B; Hohenberger P; Gebauer B; Felix R
    Rofo; 2003 Oct; 175(10):1368-75. PubMed ID: 14556106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical focal nodular hyperplasia of the liver: imaging features of nonspecific and liver-specific MR contrast agents.
    Ba-Ssalamah A; Schima W; Schmook MT; Linnau KF; Schibany N; Helbich T; Reimer P; Laengle F; Wrba F; Kurtaran A; Ryan M; Mann FA
    AJR Am J Roentgenol; 2002 Dec; 179(6):1447-56. PubMed ID: 12438034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of focal hepatic lesions with ferumoxides-enhanced T2-weighted MR imaging.
    Paley MR; Mergo PJ; Torres GM; Ros PR
    AJR Am J Roentgenol; 2000 Jul; 175(1):159-63. PubMed ID: 10882267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal eosinophilic infiltration versus metastasis in the liver: comparison of MRI findings.
    Kim TH; Kim JK; Lee JH; Lee KM; Lee EJ; Jung JY
    Hepatogastroenterology; 2009; 56(94-95):1471-6. PubMed ID: 19950812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver. II: Iron oxide-based reticuloendothelial contrast agents for MR imaging. Clinical review.
    Petersein J; Saini S; Weissleder R
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):53-60. PubMed ID: 8673716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Overview of MRI contrast media. The case of endorem].
    Duroux M
    Radiologe; 1995 Nov; 35(11 Suppl 2):S247-8. PubMed ID: 8588029
    [No Abstract]   [Full Text] [Related]  

  • 17. Black-blood diffusion-weighted EPI acquisition of the liver with parallel imaging: comparison with a standard T2-weighted sequence for detection of focal liver lesions.
    Zech CJ; Herrmann KA; Dietrich O; Horger W; Reiser MF; Schoenberg SO
    Invest Radiol; 2008 Apr; 43(4):261-6. PubMed ID: 18340250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of SPIO-enhanced MRI in the detection of malignant liver lesions.
    Savranoglu P; Obuz F; Karasu S; Coker A; Secil M; Sagol O; Igci E; Dicle O; Astarcioglu I
    Clin Imaging; 2006; 30(6):377-81. PubMed ID: 17101405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The characterization value of feridex-enhanced MR imaging for focal hepatic lesions in reference to their histological pathology].
    Yang HF; Zhou XP; Yu JQ; Song B; Guang YS; Zhang HY; Chen X
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):548-50. PubMed ID: 16042902
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging.
    Lutz AM; Willmann JK; Goepfert K; Marincek B; Weishaupt D
    Radiology; 2005 Nov; 237(2):520-8. PubMed ID: 16192317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.